Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Genoptræning Danmark ApS
APS
Active
CVR 41626798
Nibevej 6
Other social work activities without accommodation n.e.c. · NACE 8899
Est. 2020
5 employees
www.gen-dan.dk
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 2,2M
+34% vs 2023
EBITDA margin
16.6%
+64% vs 2023
Equity ratio
-10.1%
Financial strength
Net profit 2024
DKK 618K
+438% vs 2023
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
-1M
2021
0M
+100%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
DKK 2,2M
+34%
EBITDA
DKK 361K
+64%
Net profit
DKK 618K
+438%
Total assets
DKK 1,7M
+14%
Equity
DKK -173K
+88%
Employees
5
—
Company information
Legal name
Genoptræning Danmark ApS
CVR number
41626798
Legal form
Anpartsselskab
NACE code
8899 · Other social work activities without accommodation n.e.c.
Founded
28. august 2020
Share capital
DKK 40.000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene eller af den samlede direktion.
Company purpose
Selskabets formål er at hjælpe, rådgive samt assistere mennesker i deres rehabiliteringsforløb med fokus på at få dem tilbage til livet.
Contact
Address
Nibevej 6
Phone
+4528645464
Email
kontakt@gen-dan.dk
Website
www.gen-dan.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other social work activities without accommodation n.e.c.
Companies in Aalborg
All Denmark companies
Revenue
DKK millions
0M
1M
1M
2M
2M
1M
2021
1M
2022
2M
2023
2M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
-1M
2021
0M
2022
0M
2023
0M
2024
Income statement
DKK thousands
Item
2021
2022
2023
2024
Revenue
1.199
503
1.624
2.181
Staff expenses
-2.442
-792
-1.404
-1.820
EBITDA
-1.243
-289
221
361
Depreciation & amort.
-0
-2
-18
-49
EBIT
-1.243
-291
202
313
Net financials
-38
-73
-87
71
Profit before tax
-1.281
-365
115
383
Tax
-0
-0
-0
-235
Net profit
-1.281
-365
115
618
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
Total assets
76
800
1.509
1.713
Equity
-1.241
-1.606
-1.491
-173
Long-term debt
783
745
792
0
Short-term debt
534
1.661
2.208
1.886
Total debt
1.317
2.406
3.000
1.886
Financial ratios
5-year trend
EBITDA margin
16.6%
This company
15.8%
Market median
+5% vs market
2021
2024
Equity ratio
-10.1%
This company
38.2%
Market median
-126% vs market
2021
2024
Return on equity
61778300.0%
This company
18.4%
Market median
+335751530% vs market
2021
2024
Net profit margin
28.3%
This company
8.1%
Market median
+249% vs market
2021
2024
Asset turnover
1.27×
This company
1.12×
Market median
+13% vs market
2021
2024
Debt / equity
10.87×
This company
0.62×
Market median
-1653% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-08-28 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
MS
Mikkel Salling Holmgaard
Management
Management
2020
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Back To Life Holding ApS
Company
90.0%
90.0%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Back To Life Holding ApS
Genoptræning Danmark ApS
(this company)
Board network connections
Board members of Genoptræning Danmark ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Mikkel Salling Holmgaard
Management
0 companies